Dengue antibody prevalence in Buenos Aires
A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires
This study is trying to find out how many adults in Buenos Aires have antibodies against dengue by testing their blood.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1487 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundacion GESICA Academic / other |
| Locations | 1 site (Ciudad Autónoma de Buenos Aire, Buenos Aires) |
| Trial ID | NCT05919277 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the percentage of the population in the metropolitan area of Buenos Aires that has antibodies against dengue. Participants aged 18 and older will undergo a small blood draw to measure Immunoglobulin G antibodies using ELISA. The study will also characterize different dengue serotypes and assess infection by other flaviviruses. A stratified sampling design will be employed, selecting participants from various income quintiles to ensure a representative sample.
Who should consider this trial
Good fit: Ideal candidates for this study are residents of the Buenos Aires metropolitan area who are 18 years of age or older.
Not a fit: Patients who are under 18 years old or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into dengue immunity levels in the population, aiding in public health strategies.
How similar studies have performed: Similar studies have successfully assessed seroprevalence of dengue in other regions, indicating that this approach is well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * - Age ≥18 at the time of signing the informed consent. * - Resident of the Buenos Aires metropolitan area Exclusion Criteria: * To be ≤17 years old. * Inability to give informed consent.
Where this trial is running
Ciudad Autónoma de Buenos Aire, Buenos Aires
- Fundación GESICA — Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina (Recruiting)
Study contacts
- Study coordinator: Cristian Biscayart, MD
- Email: cristianbiscayart@gmail.com
- Phone: 541145204002
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.